CYRX News and Press, CryoPort Inc. From 04/30/24

Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024 PR Newswire NASHVILLE, Tenn. , April 30, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in supply chain solutions for cell & gene therapies, today announced th...

2024-03-15 11:30:03 ET UBS analyst issues BUY recommendation for CYRX on March 15, 2024 10:00AM ET. The previous analyst recommendation was Buy. CYRX was trading at $15.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...

2024-03-14 11:56:14 ET Summary Cryoport, Inc.'s financial results for Q4 2023 fell short of expectations, with revenue declining and a significant net loss. Despite the potential for growth in the cell and gene therapy market, Cryoport's revenue growth is expected to be modest. ...

2024-03-12 20:48:03 ET Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript March 12, 2024, 05:00 PM ET Company Participants Todd Fromer - IR, KCSA Strategic Communications Jerrell Shelton - CEO Mark Sawicki - Chief Scientific Officer Robert Stefanovich - C...

2024-03-12 16:08:07 ET More on CryoPort Seeking Alpha’s Quant Rating on CryoPort Historical earnings data for CryoPort Financial information for CryoPort Read the full article on Seeking Alpha For further details see: CryoPort GAAP EPS of -...

Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire FY 2023 revenue of $233.3 million , in-line with guidance Year-over-year, Commercial Cell & Gene Therapy revenue rose 33%; BioStorage/BioServices revenue increased 45% Gl...

Koninklijke KPN NV (KKPNF) is expected to report for Q4 2023 ECA Marcellus Trust I Unit (ECTM) is expected to report for Q4 2023 San Juan Basin Royalty Trust (SJT) is expected to report for Q4 2023 Avenir Wellness Solutions Inc (AVRW) is expected to report for Q4 2023 Carmell Corp...

Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 PR Newswire NASHVILLE, Tenn. , Feb. 27, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in supply chain solutions for cell & gene therapies, t...

2024-01-28 21:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-01 12:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...